Shuichi Suetani suggests that those patients who might benefit most are the least represented in clinical trials about ADHD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback